Search

everythinglearnresearchcommunity

for

Search:↓

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Bimekizumab can improve scarring alopecia in severe psoriasis.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

The patient's symptoms improved with treatment but recurred when the steroid dose was reduced, requiring ongoing therapy.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Axitinib treatment turned a man's grey hair back to black.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

New strategies like vitamin A and dextromethorphan can help reduce methotrexate side effects and improve patient adherence.

A woman with a skin disorder was found to have hepatitis C, which may be linked, and was safely treated with methotrexate.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Antituberculous drugs improved symptoms in a woman with lupus and myositis.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

Cetuximab can cause excessive eyelash growth.

Mycophenolate mofetil improved skin condition in a man with nephrogenic fibrosing dermopathy.

A medication for skin rash also unexpectedly treated hair loss in a patient.

A woman had severe reactions to methotrexate, including skin issues and organ problems, but improved after 38 days in the hospital.

RCS-01 cell therapy is safe and improves skin gene expression.

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

Rifampicin effectively treated tufted hair folliculitis with no relapse after one year.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

Risankizumab may help manage symptoms of dissecting cellulitis of the scalp.

The treatment with Shunyou and prednisone is effective and safe for lupus nephritis.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Ritlecitinib is more effective and cost-efficient than baricitinib for severe alopecia areata.